DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024.

Revenue
+4.62%
EPS
+67.0%
Free cash flow
−45.8%
Total debt
+5.07%

Quarter to September 2026, against a year earlier

190.05 4.77 −2.45%
Market cap
$12.3B
P/E
14.0×
Fwd P/E
13.0×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
12.60 17.83 13.97 11.23

+8 more quarters

P/S ratio
0.79 1.03 0.75 0.62
P/FCF ratio
7.52 8.01 6.12 5.56
P/Operating CF
21.52 29.41 32.28 15.60
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
1.51 1.75 1.47 1.33
EV/EBITDA
7.57 8.62 7.25 6.57
EV/FCF
14.37 13.59 12.00 11.94
Current Ratio
1.41 1.47 1.42 1.29
Net Debt/EBITDA
15.31 13.45 15.10 12.96
Debt/Equity
(30.19) (22.44) (22.49) (28.02)
Earnings Yield
7.94% 5.61% 7.16% 8.91%
Free Cash Flow Yield
13.30% 12.48% 16.35% 18.00%
Free Cash Flow per Share
5.82 4.95 3.30 5.35
Book value per Share
(5.62) (7.44) (7.07) (5.03)
Free Cash Flow
371.25 320.92 222.53 397.13
EV/EBIT
10.06 11.50 9.74 8.87
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026